Gong Jing-Wen, Chen Jun-Hao, Shen Ting, Jiang Jin
Department of Ophthalmology, Zhejiang Provincial People's Hospital, 158, Shangtang Road, Hangzhou, 310014, ZheJiang, China.
People's Hospital of Hangzhou Medical College, Hangzhou, 310014, ZheJiang, China.
Int Ophthalmol. 2018 Jun;38(3):1295-1300. doi: 10.1007/s10792-017-0629-9. Epub 2017 Jul 3.
To introduce a novel practical technique of self-made cryopreservative fibrin glue (SMC) applied in pterygium surgery and to assess its safety and efficacy.
Forty-eight eyes of 48 patients with nasal primary pterygium were enrolled. The patients were equally assigned to 6 groups. Self-made fibrin glue was subpackaged and, respectively, cryopreserved for 3, 7, 15 days and 1, 2 and 3 months. At each time point, the asepsis of SMC was confirmed by bacterial culture and colony counting. In each group, corresponding SMC was applied to fix the autograft after the pterygium was removed (e.g., SMC 3d for group 1 and SMC 3m for group 6). All the patients were followed up postoperatively on days 1, 3, 7 and 14 and then at months 1, 3, 6. The main outcome measures included fixation success rate within two tries, postoperative discomfort, recurrence rate and complications.
No colony growth was observed in all the fibrinogen and thrombin tubes sent. Five patients needed a second try with respective SMC during the autograft fixation, and there were no significant differences in SMC use times among the groups (P = 0.885). There were no significant differences in postoperative discomfort (day 1, 3, 7; P = 0.651, P = 0.269, P = 0.180, respectively) among the groups. By the end of 6-m follow-up, no infections and severe complications were observed in any group. The total recurrence rate was 3/48 (6%), and there were no significant differences in recurrences among the groups (P = 1.000).
SMC is safe and effective for autograft fixation in pterygium surgery. This new practical technique will benefit the patients and surgeons in developing and underdeveloped country.
介绍一种自制冷冻保存纤维蛋白胶(SMC)应用于翼状胬肉手术的新型实用技术,并评估其安全性和有效性。
纳入48例鼻侧原发性翼状胬肉患者的48只眼。将患者平均分为6组。将自制纤维蛋白胶分装后分别冷冻保存3天、7天、15天以及1个月、2个月和3个月。在每个时间点,通过细菌培养和菌落计数确认SMC的无菌性。每组在切除翼状胬肉后应用相应的SMC固定自体移植片(例如,第1组用SMC 3d,第6组用SMC 3m)。所有患者术后第1天、3天、7天和14天进行随访,然后在1个月、3个月、6个月时随访。主要观察指标包括两次尝试内的固定成功率、术后不适、复发率和并发症。
所有送检的纤维蛋白原和凝血酶管中均未观察到菌落生长。5例患者在自体移植片固定过程中需要再次使用相应的SMC,各组间SMC使用次数无显著差异(P = 0.885)。各组术后不适(第1天、3天、7天)无显著差异(分别为P = 0.651、P = 0.269、P = 0.180)。到6个月随访结束时,任何组均未观察到感染和严重并发症。总复发率为3/48(6%),各组间复发率无显著差异(P = 1.000)。
SMC在翼状胬肉手术中用于自体移植片固定是安全有效的。这种新的实用技术将使发展中国家和欠发达国家的患者和外科医生受益。